Results 151 to 160 of about 176,283 (306)

Sperm Telomere Interactions Are Impaired in Testicular Cancer Before and After Adjuvant Therapy

open access: yesAndrology, EarlyView.
ABSTRACT Background No study has yet explored telomere length or interaction in sperm nuclei of testicular cancer (TC) patients exposed to chemotherapy or radiotherapy. However, sperm telomere dynamics have emerged as a potential marker in male infertility.
Benoit Berby   +10 more
wiley   +1 more source

Pure androgen-secreting adrenal tumor (PASAT): A rare case report of bilateral PASATs and a systematic review. [PDF]

open access: yesFront Endocrinol (Lausanne), 2023
Liao Z   +6 more
europepmc   +1 more source

Testicular Adrenal Rest Tumor

open access: yesAACE Clinical Case Reports, 2023
Reza Pishdad, Nestoras Mathioudakis
openaire   +3 more sources

Perspectives on Adrenal Tumor Surgery. [PDF]

open access: yesMedicina (Kaunas)
Baston C   +6 more
europepmc   +1 more source

Laparoscopic adrenalectomy for large adrenal tumor guided by a 3D anatomic model. New frontiers in abdominal surgery. [PDF]

open access: yesJ Surg Case Rep, 2023
Giordano A   +6 more
europepmc   +1 more source

Diagnosis and treatment of ACTH-producing pituitary tumors [PDF]

open access: yes, 1978
Baur, X.   +9 more
core   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus   +5 more
wiley   +1 more source

A case of robot-assisted adrenalectomy performed for an adrenal tumor (anastomosing hemangioma) exceeding 7 cm. [PDF]

open access: yesIJU Case Rep, 2022
Nishikimi T   +6 more
europepmc   +1 more source

Renal‐vascular axis: unmasking its role in vascular endothelial growth factor‐inhibitor vascular toxicity in cancer patients

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley   +1 more source

Home - About - Disclaimer - Privacy